Nick Fischer profile

Nick Fischer

Staff Scientist

PLS / BBTD / Biosciences, Biotechnology

Email

Biography

Professional Background

Staff Scientist (2008 – present), Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory

Postdoctoral Fellow (2005 – 2008), Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory (Jeffrey Tok)

Research Assistant (2000 – 2005), University of Massachusetts – Amherst, Molecular and Cellular Biology Program (Vincent Rotello)

Education

  • Ph.D. Molecular and Cellular Biology (2005) University of Massachusetts – Amherst (Vincent Rotello)
  • B.S. Biology (1998) West Chester University of Pennsylvania

Publications

2019 2 publications

  • Lam D, Enright HA, Cadena J, Peters SKG, Sales AP, Osburn J, Soscia DA, Kulp KS, Wheeler EK, and Fischer NO (2019) Tissue-specific extracellular matrix accelerates the formation of neural networks and communities in a neuron-glia co-culture on a multi-electrode array. Scientific Reports, 9, 4159. PMID: 30858401.
  • Anikeeva A, Fischer NO, Blanchette CD, Sykulev Y (2019) Extent of MHC clustering regulates selectivity and effectiveness of T-cell responses. Journal of Immunology, 202,591-597. PMID: 30541879.

2018 2 publications

  • Belle AM, Enright HA, Sales AP, Kulp K, Osburn J, Kuhn EA, Fischer NO*, Wheeler EK* (2018) Evaluation of in vitro neuronal platforms as surrogates for in vivo whole brain systems. Scientific Reports, 8, 10820. (*Co-corresponding authors)PMID: 30018409.
  • Gilmore SF, Carpenter TS, Ingolfsson HI, Peters SKG, Henderson PT, Blanchette CD, Fischer NO (2018) Lipid composition dictates rHDL serum stability: implications for in vivo applications. Nanoscale,10, 7420-7430. PMID: 29564446.

2017 2 publications

  • Weilhammer D, Dunkle AD, Blanchette CD, Fischer NO, Corzett M, Lehmann D, Boone T, Hoeprich P, Driks A, Rasley A (2017) Enhancement of antigen-specific CD4+ and CD8+ T cell responses using a self-assembled biologic nanolipoprotein particle vaccine. Vaccine, 35, 1475-1481. PMID: 28214044.
  • Soscia DA, Belle AM, Fischer NO, Enright HA, Sales AP, Osburn J, Benett WJ, Mukerjee E, Kulp KS, Pannu S, Wheeler E (2017) Controlled placement of multiple CNS cell populations to create complex neuronal cultures. PLoS ONE, 12, e0188146. PMID: 29161298.

2013 2 publications

  • Fischer NO, Rasley A, Corzett M, Hwang MH, Hoeprich PD, Blanchette CD (2013) Colocalized delivery of adjuvant and antigen using nanolipoprotein particles enhances the immune response to recombinant antigens. Journal of the American Chemical Society, 135, 2044-2047. PMID: 23331082.
  • Weilhammer DR, Blanchette CD, Fischer NO, Alam S, Loots GG, Corzett M, Thomas C, Lychak C, Dunkle AD, Ruitenberg JJ, Ghanekar SA, Sant AJ, and Rasley A (2013) Nanolipoprotein delivery enhances immunostimulatory properties of innate immune agonists and provides protection against lethal influenza challenge. Biomaterials, 34, 10305-10318. PMID: 24075406.

2008 2 publications

  • Fischer NO, Tarasow TM, Tok JBH. (2008) Protein detection via direct enzymatic amplification of short DNA aptamers. Analytical Biochemistry, 373, 121-128. PMID: 17980857
  • Fischer NO, Tok JBH, Tarasow TM (2008) Massively parallel interrogation of aptamer sequence, structure and function. PloS ONE, 3, e2720. PMID: 18628955

2003 1 publication

  • Fischer NO, Verma A, Goodman CM, Simard JM, Rotello VM (2003) Reversible "irreversible" inhibition of chymotrypsin using nanoparticle receptors. Journal of the American Chemical Society, 125, 13387-13391. (Profiled in Editor’s Choice, Science, 302, 536) PMID: 14583034

2002 1 publication

  • Fischer NO, McIntosh CM, Simard JM, Rotello VM (2002) Inhibition of chymotrypsin through surface binding using nanoparticle-based receptors. Proceedings of the National Academy of Sciences U.S.A., 99, 5018-5023. PMID: 11929986
Nick Fischer | People